BPIA submits comments regarding Draft Guidance on Field Trial Requirements for Efficacy and Phytotoxicity Data.
The Biological Products Industry Alliance (BPIA) promotes the responsible development of safe and effective biological products including biopesticides, biostimulants, and biofertilizers as beneficial tools for commercial agriculture, forestry, golf courses, home gardens, horticulture, ornamentals, public health, and more through education, outreach, and advocacy activities at the state, federal, and international levels. Our members provide solutions that benefit growers, consumers, and the environment.
BPIA submits comments regarding Draft Guidance on Field Trial Requirements for Efficacy and Phytotoxicity Data.
BPIA applauds the bipartisan introduction of the Plant Biostimulant Act of 2023 in the Senate and the U.S. House of Representatives (H.R. 1472). BPIA thanks Senators Mike Braun (R-IN) and Alex Padilla (D-CA) as well as Congressmen Jimmy Panetta (D-CA) and Jim Baird (R-IN) for sponsoring the bill.
BPIA and other industry stakeholders suggested the PMRA consider reviewing and modernizing regulations for dual property products containing crop protection and crop health improvement properties to enable registration of these products under single label.